West Pharmaceutical Services (WST) Equity Ratio (2016 - 2025)
Historic Equity Ratio for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to 0.74.
- West Pharmaceutical Services' Equity Ratio fell 75.23% to 0.74 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.74, marking a year-over-year decrease of 75.23%. This contributed to the annual value of 0.74 for FY2024, which is 214.13% down from last year.
- As of Q3 2025, West Pharmaceutical Services' Equity Ratio stood at 0.74, which was down 75.23% from 0.74 recorded in Q2 2025.
- West Pharmaceutical Services' Equity Ratio's 5-year high stood at 0.76 during Q3 2023, with a 5-year trough of 0.67 in Q1 2021.
- For the 5-year period, West Pharmaceutical Services' Equity Ratio averaged around 0.73, with its median value being 0.74 (2025).
- In the last 5 years, West Pharmaceutical Services' Equity Ratio surged by 629.94% in 2022 and then tumbled by 214.13% in 2024.
- West Pharmaceutical Services' Equity Ratio (Quarter) stood at 0.7 in 2021, then grew by 5.33% to 0.74 in 2022, then increased by 1.34% to 0.75 in 2023, then decreased by 2.14% to 0.74 in 2024, then increased by 0.95% to 0.74 in 2025.
- Its last three reported values are 0.74 in Q3 2025, 0.74 for Q2 2025, and 0.74 during Q1 2025.